logo

Veracyte Inc. (VCYT)



Trade VCYT now with
  Date
  Headline
7/29/2020 8:21:01 AM Veracyte And MAVIDx Agree To Develop Ultra-High Volume COVID-19 Testing On The NCounter System
7/27/2020 8:19:02 AM Veracyte Appoints James Erlinger As EVP General Counsel And Secretary
6/11/2020 7:33:48 AM Veracyte Says Clinical Utility Study Demonstrates Envisia Genomic Classifier's Ability To Improve IPF Diagnosis
5/14/2020 8:20:06 AM CareDx And Veracyte Announce Partnership For Transplant Rejection Testing On NCounter System
4/23/2020 8:20:56 AM Veracyte And Yale Announce Exclusive License To Advance First Genomic Monitoring Test For Idiopathic Pulmonary Fibrosis
4/7/2020 8:18:29 AM Veracyte Names Tracy Morris As VP Of Corporate Communications And Investor Relations
1/8/2020 8:22:01 AM Veracyte Collaborates With Acerta Pharma On Oncology Therapeutics
11/2/2019 12:17:02 PM Veracyte Announces New Data That Advance Understanding Of Genomic Alterations For Thyroid Cancer
5/2/2019 9:10:25 PM Veracyte Prices Public Offering Of 5.50 Mln Shares At $23.25/shr
4/22/2019 8:38:17 AM Veracyte Names Alfred Bowie VP, Corporate And Business Development
1/3/2019 7:10:03 AM Veracyte Enters Strategic Collaboration With Johnson & Johnson Innovation In Battle Against Lung Cancer
12/5/2018 7:31:12 AM Veracyte Reports Expansion Of Envisia Genomic Classifier Early Access Program
9/26/2018 8:18:42 AM Veracyte Says Multiple Studies To Be Presented At ATA Meeting
8/31/2018 7:14:30 AM William Blair Reiterates Veracyte Inc. (VCYT) At Outperform
8/29/2018 4:09:58 PM Veracyte Names Angeline McCabe As VP, Investor Relations And Corporate Communications